Lonza’s GlycoConnect® Technology for Best-in-Class ADCs: Emerging Clinical Insights - Remon Van Geel
ELRIG Drug Discovery 2026 · 14 October 2026 · 12:20–12:50 · Auditorium 3
Lonza’s GlycoConnect® Technology for Best-in-Class ADCs: Emerging Clinical Insights - Remon Van Geel was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 1 speaker on record.
Speakers
- Remon Van Geel — Speaker Director Biochemistry, Lonza